How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

TW

NASDAQ:TWST
Get a brief AI stock analysisSaves ~ 15 minutes of your time

TW

Twist Bioscience CorpNASDAQ TWST Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is TWST undervalued compared to its fair value?

The fair value of TWST stock is hidden USD. Relative to the market price of 58.88 USD Twist Bioscience Corp is hidden.

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 989 full-t...[More about valuation]

Twist Bioscience Corp Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

3.273 $B

Price:

58.88 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.787

FINANCIALS

Twist Bioscience Corp financial for reporting period

Income Statement

0.075 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.049 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.045 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.075 B 100%
0.031 B 41%
-0.049 B -65%
-0.045 B -60%

Balance Sheet

0.7 B
0.56 B

Financial Position Analysis

Assets

0.7 B
Current Assets
0.37 B
Total non-current assets
0.33 B

Total current liabilities
0.067 B
Total non-current liabilities
0.075 B

Cash Flow Statement

-0.02 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.019 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Twist Bioscience Corp fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-32 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-51 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-25 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Twist Rating

Is TWST attractive for investment based on fundamental analysis?

TWST stock rating is hidden. Twist Bioscience Corp is a hidden by Eyestock methodology.

Get TWST Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-69

Gross Margin:

38

CFO / Debt ratio:

hidden

Current ratio:

5.853

Debt / Equity ratio:

ROE:

-32

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

TWST analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for TWST to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Twist Bioscience Corp dividends

TWST dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About TWST stock

About the company Twist Bioscience Corp

Market cap $B

3.273

Dividend yield

Shares outstanding

56.8582 B

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 989 full-time employees. The company went IPO on 2018-10-31. The firm has developed a Twist Bioscience DNA synthesis platform to industrialize the engineering of biology. The core of its platform is a technology that provides a new method of manufacturing synthetic DNA by writing DNA on a silicon chip. The firm utilizes its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. The company consists of two product lines, synthetic biology tools and NGS tools, that address different needs of its customers across a range of applications, such as synthetic genes, oligo pools, SARS-CoV-2 tools, and DNA libraries. Its synthetic biology products include Synthetic genes and gene fragments, Oligonucleotide, or Oligo pools for CRISPR gene editing. The NGS products are used for diagnostic tests for various indications like SARS-CoV-2.

TWST profile

  • Ticker

    TWST

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    31 October 2018

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    989

  • City

    South San Francisco

  • Address

    681 Gateway Blvd.

  • Cusip

    90184D100

Frequently Asked Questions

What sector does Twist operate in?

Twist operates in Healthсare sector

What is market cap of Twist?

Market cap of Twist is 3.273 USD as of 24 Jul 2024

What is market price of one TWST stock?

Market price of one TWST stock is 58.88 USD as of 24 Jul 2024

What is Twist revenue?

According to the recent report Twist revenue is 75.302

What is Twist net income?

According to the recent report Twist net icnome is -45.492

What is Twist net income growh rate?

Net income growth rate of Twist is 24